1/17
Looks like no tags are added yet.
Risk factors for drug-induced kidney disease
Advanced age > 70
Male gender
African American
Pre-existing renal disease
Diabetes
Heart failure
Nephrotoxic drugs
Sepsis
Volume depletion
Cirrhosis surgery
Shock
Acidosis
NSAID Nephropathy…
Mechanism
Ischemic kidney damage
Decreased synthesis of renal vasodilator
Reduced renal perfusion and pressure
Risk Factors for NSAID Nephropathy
Age > 60
Pre-existing kidney disease
Hepatic disease
CHF
Volume depletion lupus
ACEi/ARB usage
NSAID Nephropathy Prevention?
→ avoid use in high-risk patients
Maintain adequate hydration if decided to do so
Treatment
DC NSAID and other nephrotoxic meds
Reversible recovery within 3 - 5 days
NSAIDs Brand and Generic
Etodolac (Lodine)
Nabumetone (Relafen)
Sulindac (Clinoril)
Cyclosporine and Tacrolimus Nephropathy
Presentation
Occurs within days of initiation
Rise in Scr
Hypertension
Hyperkalemia
Sodium retention
Renal tube acidosis
Hypomagnesemia
Prevention of Cyclosporine and Tacrolimus Nephropathy?
→ PD/PK monitoring + decreased doses when used with other immunosuppresants
→ TREATMENT:
Acute injury: dose reduction or discontinuation of interacting meds
Chronic injury: NOT dose related and IRREVESIBLE
SGLT-2 Inhibitor Nepropathy…
Canagliflozin and dapagliflozin AKI complication
Osmotic diuresis leads to VOLUME DEPLETION
Sodium chloride delivery vasoconstricts and REDUCES GFR
RISK FACORS?
Older age
ACEi, ARB, NSAID, Diuretic concomitant use
Volume depletion
TX?
DC SGLT2i
IV fluids for volume depletion
Aminoglycoside Nephrotoxicity Ranking?
Neomycin (most)
Gentamicin
Tobramycin
Amikacin (least)
Aminoglycoside Nephrotoxicity
Toxicity related to cationic charge of the drug…
Select alt agents when possible
Avoid volume depletion
Limit total dose
Radiographic Contrast Media-Induced Nephrotoxicity (CIN)
→ presents within first 24-48 hours after administration
Scr PEAKS between 3-4 days after exposure
Recovery 7-10 days
Radiographic Contrast Media-Induced Nephrotoxicity (CIN) Mechanism
Renal ischemic (systemic hypotension and acute vasoconstriction)
Direct cellular toxicity
RISK FACTORS:
Pre-existing kidney disease
Decreased renal flow
Diabetes
Nephrotoxins
Radiographic Contrast Media-Induced Nephrotoxicity (CIN) PREVENTION?
Use alt. Imaging
Contrast: use noniodinated contrast, minimize contrast volume/dose
Hydration?
Isotonic saline: 1 - 1.5 mL/kg/hr to maintain urine rate of 150 mL/hr
3 to 12 hours prior and continue 6 - 24 hours AFTER exposure
URGENT: 0.9 NaCl 3 mL/kg/hr
1 hour prior and 6 hours after
Amphotericin B Nephrotoxicity Presentation
Non-oliguria (normal urine output)
Rise in Scr and BUN
Renal tubular potassium, sodium, and magnesium wasting
Distal renal tubular acidosis
Tubular dysfunction 1 - 2 weeks after initiation
Amphotericin B Nephrotoxicity MoA
DIRECT tubular epithelial cell toxicity
Necrosis of proximal tubular cells
Afferent arterioar vasoconstritction
Reduction in renal blood GFR
Amphotericin B Nephrotoxicity RISKS
Short infusion time
Volume depletion
Hypokalemia
large/cumulative doses
Amphotericin B Nephrotoxicity Prevention?
Liposomal formulation
Limit cumulative doses
INCREASING INFUSION TIME
Hydration:
1 L of 0.9 NaCl IV daily during therapy
10 - 15 mL/kg prior to amphotericin B
Amphotericin B Nephrotoxicity Treatment?
DC therapy and use other antifungal
Drug-Induced Acute Interstital Nephritis
Systemic manifestation of hypersensitivity reaction
Presents: fever, rash, arthralgia, eosinophilila
Drugs:
Penicillin
Cephalopsorin
NSAIDs
Diuretics
PPI
Treatment:
DC offending
IF RENAL FAILURE > 7 days, steroids
High dose prednisone 1 mg/kg/day for 4-6 weeks with 4 week taper
Drug-induced Post-renal acute renal failure
→ obstruction of urine flow from crystal formation or retroperitoneal fibrosis
Drugs
Acyclovir
Sulfonamides
Methotrexate
High dose vitamin C
Indinavir, atazanavir
Prevention/Treatment?
Urine alkalinization